Edition:
Deutschland

Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

83.71USD
13 Dec 2019
Change (% chg)

$-1.10 (-1.30%)
Prev Close
$84.81
Open
$84.52
Day's High
$84.66
Day's Low
$83.60
Volume
482,597
Avg. Vol
516,547
52-wk High
$84.98
52-wk Low
$62.00

About

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics... (more)

Buy/Sell

Sell Hold Buy
2.13 Mean rating from 15 analysts

Overall

Beta: 1.43
Market Cap(Mil.): $26,245.95
Shares Outstanding(Mil.): 309.47
Dividend: 0.18
Yield (%): 0.85

UPDATE 2-Ackman's Pershing Square makes new bet on Agilent Technologies

BOSTON, Dec 9 Billionaire investor William Ackman's hedge fund Pershing Square Capital Management said Monday it bought shares in testing equipment company Agilent Technologies Inc, only its second new investment this year as the fund has reported a 51% return.

Ackman's Pershing Square makes new bet on Agilent Technologies

BOSTON, Dec 9 Billionaire investor William Ackman's hedge fund Pershing Square Capital Management has made a new bet on Agilent Technologies Inc, according to a regulatory filing made on Monday.

Qiagen shares surge as diagnostics group says open to takeover talks

FRANKFURT Qiagen NV shares jumped to their highest in almost 19 years on Monday after the German genetic testing company said it would start talks with several potential suitors.

Qiagen shares surge as diagnostics group says open to takeover talks

FRANKFURT, Nov 18 Qiagen NV shares jumped to their highest in almost 19 years on Monday after the German genetic testing company said it would start talks with several potential suitors.

WHO updates its essential medicines list, adds cancer and stroke drugs

GENEVA, July 9 The World Health Organization published an updated list of "essential medicines" on Tuesday, adding drugs for cancer, stroke, rheumatoid arthritis and inflammatory bowel disease among the treatments that should be seen as the standard.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.24%
Rohstoffe +0.50%
Industrie +0.54%
Konjunktur abhängige Waren & Dienstleistungen +0.62%
Konjunktur unabhängige Waren & Dienstleistungen +0.21%
Finanzindustrie +0.15%
Pharma +0.50%
Technologie -0.02%
Telekommunikation +1.13%

Nachrichten aus der Wirtschaft